IVF Devices Market

IVF Devices Market Size, Share, and Forecast Outlook 2025 to 2035

The global IVF devices market is forecast to reach USD 25.1 billion by 2035, up from USD 4.4 billion in 2025. During the forecast period, the industry is projected to register at a CAGR of 19.0%. Rising infertility rates are driving IVF demand as people's lifestyles change and they delay starting families.

Precision tools and automation are improving success rates as technology advances. Medical tourism is increasing access to IVF services worldwide. Favorable reimbursement policies and greater awareness of assisted reproductive technologies are driving market growth and accessibility.

Quick Stats of IVF Devices Market

• IVF Devices Market Size (2025): USD 4.4 billion
• Projected IVF Devices Market Size (2035): USD 25.1 billion
• Forecast CAGR of IVF Devices Market (2025 to 2035): 19.0%
• Leading Technology Segment of IVF Devices Market: Frozen Embryo IVF
• Key Growth Regions of IVF Devices Market: France, China, United States
• Key Players of the IVF Devices Market: Cook Group, CooperSurgical Fertility Company, FUJIFILM Irvine Scientific, Thermo Fisher Scientific, others.

Metric	Value
Industry Size (2025E)	USD 4.4 billion
Industry Size (2035F)	USD 25.1 billion
CAGR (2025-2035)	19.0%

The IVF devices market is projected to expand from USD 4.4 billion in 2025 to USD 10.5 billion by 2030, signifying an initial acceleration phase. This increase is anticipated to be bolstered by enhanced patient awareness, the expansion of insurance coverage, and a broader array of IVF procedures available in public and private fertility clinics. The growing utilization of time-lapse embryo imaging, microfluidics-based sperm sorting, and cryopreservation systems is expected to drive equipment sales in the coming years.

The significant double-digit growth indicates that clinics are likely to invest substantially in enhancing laboratory capabilities to distinguish themselves in a competitive environment. Regulatory approvals for advanced reproductive technologies across various regions will expedite adoption cycles, resulting in steady demand for devices.

From 2030 to 2035, the market is projected to increase from USD 10.5 billion to USD 25.06 billion, indicating a significant growth phase propelled by technological consolidation and the globalization of services. The shift towards comprehensive reproductive care centers will incorporate genetic testing, AI-assisted embryo selection, and automated culture systems, thereby elevating capital investment per clinic.

Emerging economies are expected to surpass developed regions in percentage growth due to the swift expansion of healthcare infrastructure. The year-on-year increases surpassing USD 3 billion in the final years indicate a maturity phase in which device replacement, rather than initial purchases, serves as a primary revenue driver.

Top IVF Devices Market Dynamics

The global IVF equipment market is expanding rapidly as infertility concerns gain traction and treatment choices become more accessible. Increased knowledge, supporting healthcare legislation, and expanded clinical infrastructure have made IVF a feasible option for couples seeking assisted reproduction. The incorporation of sophisticated technologies and improved procedural guidelines is helping to increase treatment success rates.

IVF equipment are crucial to ensure the precision, efficiency, and safety of reproductive treatments. From the first phases of gamete handling to embryo culture and transfer, sophisticated technology ensures the precision needed for the best patient outcomes. Continuous advancements in hardware and related technologies are making IVF procedures more predictable, successful, and scalable in both developed and emerging markets.

Rising Infertility Rates as a Primary Growth Catalyst

Increasing infertility rates will drive the IVF devices market. Infertility is the inability to conceive or carry a pregnancy after one year of regular, unprotected sexual activity. Infertility is rising due to lifestyle changes, delayed pregnancies, and stress.

Assisted reproductive technologies use IVF equipment for egg retrieval, embryo culture, and embryo transfer to help infertile couples conceive and become pregnant. The World Health Organization (WHO), a Switzerland-based UN agency that promotes health, keeps the world safe, and serves the vulnerable, reported in April 2023 that 17.5% of the global adult population, or 1 in 6 people, experience infertility.

Technological Innovations Enhancing IVF Success Rates

Innovations in IVF technologies also drive the market. ICSI, PGT, and time-lapse imaging have greatly improved IVF success rates. These innovations boost fertility treatments and lower offspring genetic disorder risks.

The use of advanced IVF incubators, imaging systems, and micromanipulators has improved precision and efficiency. Technological advancement is necessary to meet rising demand for effective and reliable fertility solutions, driving market growth.

Advanced Equipment Improving Precision and Treatment Outcomes

IVF technology improves fertility treatment success. These sophisticated tools improve IVF precision and efficacy. IVF relies on these devices, from cutting-edge incubators that mimic the human body to real-time imaging systems that track embryo development. Continuous innovation in IVF devices ensures they can handle modern fertility treatments, improving patient outcomes and giving hope to infertile patients.

Elevated Procedural Costs Render Treatments Unaffordable

One major concern is the high cost of IVF procedures and associated devices, which makes treatment inaccessible to many patients, particularly those in developing countries. For instance, in the United States, a single IVF cycle can cost between $12,000 and $14,000, not including medication, limiting adoption among middle-income populations.

Compliance with Stringent Regulatory Frameworks May Delay New Approaches

The market is subject to stringent regulatory frameworks that vary by region, which can lead to product approval delays and increased compliance costs. For example, the European Union's Medical Device Regulation (MDR) has imposed more stringent clinical and safety standards, affecting the time-to-market of innovative IVF solutions.

Limited Success Rates May Discourage Individuals from Opting for IVF Treatment

Another important constraint is the physical and emotional cost of IVF procedures. Multiple treatment cycles are frequently required, with no assurance of success. According to the CDC, IVF success rates in women under 35 are around 40%, and they drop significantly with age.

This, combined with the side effects of fertility drugs and potential complications such as ovarian hyper stimulation syndrome (OHSS), causes many patients to stop treatment.

Top Regions Driving IVF Treatment Devices Market Growth

North America is a leader in the global IVF devices market, due to high adoption rates of advanced fertility treatments, well-established healthcare infrastructure, and an increasing prevalence of infertility issues. The presence of major market players, as well as favourable reimbursement policies, helps to maintain the region's market dominance.

Europe is a significant market for IVF devices, driven by supportive government initiatives, rising demand for fertility treatments, and the presence of skilled healthcare professionals. Countries such as the United Kingdom, Germany, and France are making significant investments in IVF technology, which is driving regional market growth.

Asia Pacific is emerging as a lucrative market for IVF devices and consumables, driven by rising disposable income, heightened awareness of infertility treatments, and expanding healthcare infrastructure. Countries such as China, India, and Japan are experiencing a surge in demand for IVF procedures, leading to market expansion in the region.

Country-Wise Outlook

Countries	CAGR (2025 to 2035)
United States	17.5%
China	19.7%
India	22.3%

United States A Mature and Expanding IVF Devices Market Driven by High Infertility Rates and ART Adoption

The United States is one of the world's largest and most mature markets for IVF devices, owing to high infertility rates, rising maternal age, and growing awareness of assisted reproductive technologies (ART). According to the Centers for Disease Control and Prevention (CDC), approximately one in every five married women aged 15 to 49 who have never had a child are unable to conceive after a year of trying, highlighting the significant patient pool that relies on fertility treatments.

Technological advancement continues to be a key growth driver in the US IVF devices market. The country is a global hub for medical innovation, with fertility clinics implementing cutting-edge technologies such as time-lapse embryo imaging, AI-powered embryo selection algorithms, and robotic-assisted micromanipulation systems. For example, clinics such as Boston IVF and CCRM are incorporating AI solutions to enhance embryo viability assessment and improve success rates.

The United States Food and Drug Administration (FDA) ensures that IVF devices meet stringent safety and efficacy standards. While this promotes patient trust, it also increases compliance costs and lengthens development timelines for manufacturers. However, recent fast-track approvals for fertility-related diagnostic tools suggest that the regulatory environment is favorable for innovations addressing reproductive health challenges.

China IVF Devices Market Accelerates Amid Policy Shifts and Fertility Challenges

China's IVF device market is rapidly expanding, driven by demographic shifts, government policy changes, and changing societal attitudes toward fertility. With the repeal of the one-child policy and the implementation of the three-child policy in 2021, the government has acknowledged declining birth rates. It is actively encouraging the use of assisted reproductive technologies (ART) to address population challenges. As of 2023, China's birth rate has reached its lowest level in decades, resulting in increased demand for fertility services and equipment.

A major driver is the high prevalence of infertility, with estimates indicating that 12-18% of Chinese couples experience fertility problems. This trend is exacerbated by a growing preference for delayed parenthood, particularly in urban areas, where women are increasingly opting to pursue careers before starting families. As a result, demand for IVF devices, including incubators, cryopreservation equipment, and micromanipulation systems, is increasing in fertility clinics throughout Tier 1 and Tier 2 cities, such as Beijing, Shanghai, and Chengdu.

The National Health Commission (NHC) closely monitors China's IVF regulatory framework, and fertility clinics are strictly licensed. Although this has established a baseline of care quality, it also restricts the number of facilities authorized to perform IVF, resulting in a supply-demand gap. Nonetheless, more than 520 IVF centers were operating legally as of 2022, a figure that has been steadily increasing.

France Public Healthcare Support Fueling Steady Growth in IVF Devices Market

France's IVF device market is expanding steadily, primarily driven by strong public healthcare support and widespread insurance coverage. The French social security system covers up to six IVF attempts for women under the age of 43, significantly reducing the financial burden on patients while also creating consistent demand for IVF equipment, accessories, and consumables.

The increasing availability of ART services is a major driver in the country. Recent bioethics law reforms have made it possible for single women and lesbian couples to access IVF, which was previously only available to heterosexual couples experiencing fertility issues. This policy change has broadened the patient base and encouraged increased use of IVF devices in both public and private clinics.

France also takes the lead in implementing quality and safety standards under the EU Medical Device Regulation (MDR). IVF devices undergo strict certification processes before being approved, which ensures safety but can create regulatory barriers for new entrants, particularly startups and smaller suppliers seeking to enter the French market.

Analyzing IVF Devices Market by Leading Segments

Accessories & Disposables High-Demand Segment Ensuring Safety and Efficiency in IVF Procedures

Accessories and disposables are among the most popular and widely used segments in the IVF (In-Vitro Fertilization) Devices Market due to their consistent demand and critical role in every IVF procedure. The popularity of this segment is largely driven by the demand for sterile, single-use products that reduce the risk of contamination and ensure regulatory compliance with safety standards.

Because IVF cycles are repeated and tailored to individual patients, clinics require a steady supply of high-quality disposables, making this a high-volume and high-revenue segment.

Reagents and media serve as the foundation for IVF procedures, providing the environment required for embryo fertilization and culture. This includes culture media, which provides the nutrients and conditions required for embryo growth, as well as cryoprotectants, which are used during the freezing and thawing processes.

Furthermore, specialized reagents such as sperm preparation solutions and hormonal supplements are critical in increasing the success rates of IVF treatments.

Frozen Embryo IVF Enhancing Flexibility and Pregnancy Outcomes While Minimizing OHSS Risk

Frozen Embryo IVF involves freezing embryos after fertilization for future use. This method allows for more flexibility in timing the embryo transfer, such as synchronizing with the woman's natural menstrual cycle or optimizing the uterine environment, which can increase the chances of implantation and pregnancy. Furthermore, frozen embryo transfer may reduce the risk of ovarian hyperstimulation syndrome (OHSS) caused by the use of fertility medications.

Donor Egg IVF is the use of eggs donated by another woman, usually when the intended mother is unable to produce viable eggs. This method offers an alternative for couples experiencing female infertility and has made a significant contribution to the global success of IVF treatments. Donor Egg IVF has helped many couples realize their dream of parenthood by utilizing donated eggs from healthy, young donors.

Fertility Clinics Driving IVF Market Growth through Specialized Services and Advanced Technologies

Fertility clinics are a major segment of the IVF market, providing specialized reproductive medicine services. These clinics offer a variety of IVF services, including fertility screenings, ovarian stimulation, egg retrieval, embryo transfer, and preimplantation genetic testing.

With the growing demand for assisted reproductive technologies (ART), fertility clinics are seeing an increase in patient traffic, which is driving the adoption of advanced IVF devices and consumables to improve success rates and patient outcomes.

Hospitals, particularly those with dedicated reproductive medicine departments, make up a sizable portion of the end-user segment. These institutions provide a variety of fertility treatments, including IVF, and are frequently outfitted with cutting-edge technology and experienced medical staff.

The incorporation of advanced IVF technologies into hospitals not only improves their service offerings, but also attracts a larger patient base seeking comprehensive fertility treatment. As hospitals continue to expand their reproductive health services, the demand for IVF devices and consumables is expected to increase significantly.

Competitive Analysis

The IVF (In-Vitro Fertilization) devices market is highly competitive and rapidly evolving, owing to rising infertility rates, delayed parenthood, and advances in assisted reproductive technologies. The market is fragmented, with both established medical device companies and emerging players innovating in areas like embryo culture, cryopreservation, and micromanipulation systems. Continuous investment in R&D is a critical competitive factor, as companies strive to create more efficient, less invasive, and accurate IVF tools.

Market competition is primarily driven by technological innovation, regulatory approvals, and clinical success rates. Companies that provide integrated IVF platforms, such as real-time imaging, AI-based embryo grading, and automated laboratory systems, are gaining traction because of their ability to improve outcomes and reduce human error. Disposable and consumable products, such as embryo transfer catheters and culture media, are also important battlegrounds because they generate recurring revenue and must meet stringent safety and sterility requirements.

The rising demand for cryopreservation techniques, particularly elective embryo freezing and fertility preservation, has fueled competition in the development of advanced freezing and thawing systems. Furthermore, regions such as Asia-Pacific and Latin America are seeing increased market entry as medical tourism and awareness grow, prompting global players to expand distribution networks and localize production.

Key players in the market include Cook Group, CooperSurgical Fertility Company, FUJIFILM Irvine Scientific, Thermo Fisher Scientific, Fertilis, EMD Serono Inc., Vitrolife AB, and other notable players.

Recent Developments

• In June 2025, Thermo Fisher Scientific introduced the Orbitrap Astral Zoom and Orbitrap Excedion Pro mass spectrometers at ASMS 2025, which are intended to improve proteomic profiling for fertility research.
• In April, 2025, Thermo Fisher Scientific has committed USD 2 billion over four years to expand its U.S. manufacturing and R&D facilities, including lines dedicated to reproductive health consumables.
• In May 2024, Cook Medical has signed a letter of intent with Astorg, a well-known private equity firm known for its successful global healthcare investments, to acquire Cook's Reproductive Health division, "Cook ART". The transaction includes products for in vitro fertilization (IVF) and assisted reproductive technology (ART).

Segmentation of IVF Devices Market

• By Product :

  • Instruments
  • Accessories & Disposables
  • Reagents & Media

• By Technology :

  • Fresh Embryo IVF
  • Frozen Embryo IVF
  • Donor Egg IVF

• By End User :

  • Hospitals
  • Fertility Clinics
  • Surgical Centers
  • Clinical Research Institutes

• By Region :

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • East Asia
  • South Asia & Pacific
  • Middle East & Africa